🔗 Share this article

An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

Based on the social media company, the platform has removed problematic material and prohibited related keywords and search suggestions. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.

After moments of entering one community, a vendor shared contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these groups, messages display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant health risks”.